AC Immune (ACIU) FCF Margin (QoQ) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -293,487.00 |
| Sep 30, 2025 | -77,115.00 |
| Jun 30, 2025 | 70,677.00 |
| Mar 31, 2025 | -244,860.00 |
| Dec 31, 2024 | 58,465.00 |
| Sep 30, 2024 | -1.07 Mn |
| Dec 31, 2020 | -92,534.00 |
| Sep 30, 2020 | -2,820.00 |
| Jun 30, 2020 | -126,126.00 |
| Mar 31, 2020 | 103,273.00 |
| Dec 31, 2019 | -186,252.00 |
| Sep 30, 2019 | 183,775.00 |
| Jun 30, 2019 | -117,372.00 |
| Mar 31, 2019 | 142,072.00 |
| Dec 31, 2018 | -82,444.00 |
| Sep 30, 2018 | -17,612.00 |
| Jun 30, 2018 | 51,007.00 |
| Mar 31, 2018 | -19.11 Mn |
| Dec 31, 2017 | 285.41 Mn |
| Sep 30, 2017 | -266.28 Mn |
| Jun 30, 2017 | -44,909.00 |
| Mar 31, 2017 | -36.00 |
| Dec 31, 2016 | -124,463.00 |
| Sep 30, 2016 | 67,793.00 |
| Jun 30, 2016 | 153,905.00 |
| Mar 31, 2016 | -62,256.00 |